Manon van Engeland

16.2k total citations · 4 hit papers
158 papers, 12.2k citations indexed

About

Manon van Engeland is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Manon van Engeland has authored 158 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 52 papers in Pathology and Forensic Medicine and 50 papers in Oncology. Recurrent topics in Manon van Engeland's work include Epigenetics and DNA Methylation (72 papers), Genetic factors in colorectal cancer (50 papers) and Colorectal Cancer Screening and Detection (26 papers). Manon van Engeland is often cited by papers focused on Epigenetics and DNA Methylation (72 papers), Genetic factors in colorectal cancer (50 papers) and Colorectal Cancer Screening and Detection (26 papers). Manon van Engeland collaborates with scholars based in Netherlands, United States and Belgium. Manon van Engeland's co-authors include Frans C. S. Ramaekers, Bert Schutte, Chris Reutelingsperger, James G. Herman, Matty P. Weijenberg, Adriaan P. de Bruı̈ne, Piet A. van den Brandt, Stephen B. Baylin, Wim Van Criekinge and Veerle Melotte and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Manon van Engeland

156 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Annexin V-Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure

1998 1.6k citations Manon van Engeland et al. profile →
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

2004 858 citations Kornel E. Schuebel, Manon van Engeland et al. profile →
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

2002 701 citations Edward Gabrielson, Manon van Engeland et al. profile →
Analysis of DNA methylation in cancer: location revisited

2018 491 citations Alexander Koch, Sophie C. Joosten et al. profile →

Peers

Countries citing papers authored by Manon van Engeland

Since Specialization

Citations

This map shows the geographic impact of Manon van Engeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manon van Engeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manon van Engeland more than expected).

Fields of papers citing papers by Manon van Engeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manon van Engeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manon van Engeland. The network helps show where Manon van Engeland may publish in the future.

Co-authorship network of co-authors of Manon van Engeland

This figure shows the co-authorship network connecting the top 25 collaborators of Manon van Engeland. A scholar is included among the top collaborators of Manon van Engeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manon van Engeland. Manon van Engeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification 2023 ·Oncology Letters ·(unknown), Iryna Samarska, Andrés Matoso, (unknown), Marcella Baldewijns, Christina Hulsbergen‐van de Kaa, (unknown), Guido M.J.M. Roemen, (unknown), Manon van Engeland, Axel zur Hausen, Leo J. Schouten, Kim M. Smits	5
2	Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review 2018 ·Clinical Epigenetics ·Muriel X.G. Draht, (unknown), Alexander Koch, Heike I. Grabsch, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte, Kim M. Smits	34
3	A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients 2016 ·Clinical Cancer Research ·Iris J.H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J.B. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland	44
4	Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome 2015 ·Clinical Cancer Research ·Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt, Manon van Engeland	49
5	Body Size, Physical Activity, Early-Life Energy Restriction, and Associations with Methylated Insulin-like Growth Factor–Binding Protein Genes in Colorectal Cancer 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Colinda C.J.M. Simons, Piet A. van den Brandt, Coen D.A. Stehouwer, Manon van Engeland, Matty P. Weijenberg	19
6	CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer 2014 ·Clinical Cancer Research ·Arjen H.G. Cleven, Sarah Derks, Muriel X.G. Draht, Kim M. Smits, Veerle Melotte, Leander Van Neste, (unknown), Valérie Jooste, Caroline Chapusot, Matty P. Weijenberg, James G. Herman, Adriaan P. de Bruı̈ne, Manon van Engeland	30
7	Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood 2014 ·Cancer Prevention Research ·Veerle Melotte, Joo Mi Yi, Marjolein H.F.M. Lentjes, Kim M. Smits, Leander Van Neste, Hanneke E.C. Niessen, Kristien Wouters, Joost Louwagie, Kornel E. Schuebel, James G. Herman, Stephen B. Baylin, Wim Van Criekinge, Gerrit A. Meijer, Nita Ahuja, Manon van Engeland	31
8	CD44 and OTP Are Strong Prognostic Markers for Pulmonary Carcinoids 2013 ·Clinical Cancer Research ·Dorian R.A. Swarts, Mieke E.R. Henfling, Leander Van Neste, Robert‐Jan van Suylen, Anne‐Marie C. Dingemans, Winand N.M. Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, Wim Van Criekinge, Manon van Engeland, Frans C.�S. Ramaekers, Ernst‐Jan M. Speel	67
9	Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines 2013 ·Clinical Cancer Research ·Jana Jeschke, Heather M. O’Hagan, Wei Zhang, Rajita Vatapalli, Marília Freitas Calmon, Ludmila Danilova, (unknown), Leander Van Neste, (unknown), Manon van Engeland, Edward Gabrielson, Kornel E. Schuebel, Andreas Winterpacht, Stephen B. Baylin, James G. Herman, Nita Ahuja	68
10	Chromosome 5q Loss in Colorectal Flat Adenomas 2012 ·Clinical Cancer Research ·Quirinus J.M. Voorham, Beatriz Carvalho, (unknown), Nicole C.T. van Grieken, Sandra Mongera, Eveline Rondagh, Mark A. van de Wiel, Ekaterina S. Jordanova, Bauke Ylstra, (unknown), Heike I. Grabsch, Björn Rembacken, Tomio Arai, Adriaan P. de Bruı̈ne, Silvia Sanduleanu, Philip Quirke, Chris J.J. Mulder, Manon van Engeland, Gerrit A. Meijer	26
11	DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT 2011 ·Cancer Prevention Research ·Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx, Carolina A.J. Khalid-de Bakker, Jochim S. Terhaar sive Droste, Veerle Melotte, Daisy Jonkers, Ad Masclee, Sandra Mongera, Madeleine Grooteclaes, Joost Louwagie, Wim Van Criekinge, Veerle M.H. Coupé, Chris J. Mulder, Manon van Engeland, Beatriz Carvalho, Gerrit A. Meijer	45
12	Test Performance of Immunologic Fecal Occult Blood Testing and Sigmoidoscopy Compared with Primary Colonoscopy Screening for Colorectal Advanced Adenomas 2011 ·Cancer Prevention Research ·Carolina A.J. Khalid-de Bakker, Daisy Jonkers, Silvia Sanduleanu, Adriaan P. de Bruı̈ne, Gerrit A. Meijer, (unknown), Manon van Engeland, Reinhold W. Stockbrügger, Ad Masclee	37
13	A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer 2011 ·Clinical Cancer Research ·Kim M. Smits, Trupti Paranjape, Sunitha Nallur, Kristien Wouters, Matty P. Weijenberg, Leo J. Schouten, Piet A. van den Brandt, Fred T. Bosman, Joanne B. Weidhaas, Manon van Engeland	85
14	Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! 2011 ·Clinical Cancer Research ·Iris J.H. van Vlodrop, Hanneke E.C. Niessen, Sarah Derks, Marcella Baldewijns, Wim Van Criekinge, James G. Herman, Manon van Engeland	113
15	Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer 2011 ·Clinical Cancer Research ·Joo Mi Yi, Mashaal Dhir, Leander Van Neste, Stephanie R. Downing, Jana Jeschke, Sabine C. Glöckner, Marília Freitas Calmon, Craig M. Hooker, Juan M. Funes, Chris Boshoff, Kim M. Smits, Manon van Engeland, Matty P. Weijenberg, Christine A. Iacobuzio–Donahue, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin, Nita Ahuja	118
16	Viewing the Epigenetics of Colorectal Cancer through the Window of Folic Acid Effects 2010 ·Cancer Prevention Research ·Manon van Engeland, James G. Herman	6
17	Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Dean A. Troyer, M. Scott Lucia, (unknown), (unknown), Marcella Baldewijns, (unknown), Manon van Engeland, (unknown), Katja Bierau, Joost Louwagie, Joseph Bigley	38
18	Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer 2009 ·Cancer Epidemiology Biomarkers & Prevention ·Stefan de Vogel, Kristien Wouters, Ralph W.H. Gottschalk, Frederik‐Jan van Schooten, Anton F.P.M. de Goeij, Adriaan P. de Bruı̈ne, (unknown), Piet A. van den Brandt, Matty P. Weijenberg, Manon van Engeland	77
19	Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells 2007 ·Cancer Research ·Debby M.E.I. Hellebrekers, Veerle Melotte, Emmanuelle Viré, Elise Langenkamp, Grietje Molema, François Fuks, James G. Herman, Wim Van Criekinge, Arjan W. Griffioen, Manon van Engeland	113
20	Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications 2006 ·Cancer Research ·Debby M.E.I. Hellebrekers, Karolien Castermans, Emmanuelle Viré, Ruud P.M. Dings, Nicole Hoebers, Kevin H. Mayo, Mirjam G.A. oude Egbrink, Grietje Molema, François Fuks, Manon van Engeland, Arjan W. Griffioen	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact